Cargando…

Erlotinib: An enhancer of radiation therapy in nasopharyngeal carcinoma

The aim of this study was to explore the effects of erlotinib combined with radiation on human nasopharyngeal carcinoma (NPC) radiosensitivity using the CNE1 and CNE2 cell lines. Human NPC cells were treated with erlotinib and/or radiation. The effect of erlotinib on the radiosensitivity of the cell...

Descripción completa

Detalles Bibliográficos
Autores principales:	ZHANG, HUAN-HUAN, YUAN, TAI-ZE, LI, JIAN, LIANG, YIN, HUANG, LAI-JI, YE, JIA-CAI, ZHENG, RONG-HUI, XIE, GUO-FENG, ZHANG, XIU-PING
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797307/ https://www.ncbi.nlm.nih.gov/pubmed/24137317 http://dx.doi.org/10.3892/etm.2013.1245

Ejemplares similares

Radiation-induced sarcomas of the head and neck in post-radiation nasopharyngeal carcinoma
por: Yang, Qiuxia, et al.
Publicado: (2016)

Efficacy of bevacizumab combined with erlotinib for advanced hepatocellular carcinoma: a single-arm meta-analysis based on prospective studies
por: He, Liyun, et al.
Publicado: (2019)

Long-Term Results of Concurrent Chemoradiotherapy for Advanced N2-3 Stage Nasopharyngeal Carcinoma
por: Yin, Li, et al.
Publicado: (2015)

Radiation-induced lymphopenia correlates with survival in nasopharyngeal carcinoma: impact of treatment modality and the baseline lymphocyte count
por: Xie, Xiaoxue, et al.
Publicado: (2020)

Replanning Criteria and Timing Definition for Parotid Protection-Based Adaptive Radiation Therapy in Nasopharyngeal Carcinoma
por: Yao, Wei-Rong, et al.
Publicado: (2015)

Blocking ROR1 enhances the roles of erlotinib in lung adenocarcinoma cell lines
por: Wang, Hui-Li, et al.
Publicado: (2019)

Erlotinib plus tivantinib versus erlotinib alone in patients with previously treated stage IIIb/IV non–small-cell lung cancer: A meta-analysis based on randomized controlled trials
por: Deng, Huan, et al.
Publicado: (2020)

Polyethylene Glycol-Coated Graphene Oxide Loaded with Erlotinib as an Effective Therapeutic Agent for Treating Nasopharyngeal Cancer Cells
por: Lan, Ming-Ying, et al.
Publicado: (2020)

Prognostic value of hypertension in patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy
por: Yin, Wen-Jing, et al.
Publicado: (2021)

MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma
por: Zhuang, Hongqing, et al.
Publicado: (2016)

Prognostic value of radiation interruption in different periods for nasopharyngeal carcinoma patients in the intensity‐modulated radiation therapy era
por: Yang, Xing‐Li, et al.
Publicado: (2020)

Enhancement of Pancreatic Cancer Therapy Efficacy by Type-1 Matrix Metalloproteinase-Functionalized Nanoparticles for the Selective Delivery of Gemcitabine and Erlotinib
por: Yin, Na, et al.
Publicado: (2020)

Radiation-induced brachial plexopathy in patients with nasopharyngeal carcinoma: a retrospective study
por: Cai, Zhaoxi, et al.
Publicado: (2016)

Treating radiation‑related nasopharyngeal necrosis with endostar in patient with nasopharyngeal carcinoma: A report of two cases and a literature review
por: Tang, Jie, et al.
Publicado: (2023)

Functionalized MoS(2)-erlotinib produces hyperthermia under NIR
por: Zhang, Chen, et al.
Publicado: (2019)

A Study of Radiation-Induced Cerebral Vascular Injury in Nasopharyngeal Carcinoma Patients with Radiation-Induced Temporal Lobe Necrosis
por: Ye, Jianhong, et al.
Publicado: (2012)

Yiqi Formula Enhances the Antitumor Effects of Erlotinib for Treatment of Triple-Negative Breast Cancer Xenografts
por: Liao, Ming-juan, et al.
Publicado: (2014)

Clinical and imaging characteristics of 53 ulcers of post-radiation nasopharyngeal necrosis in patients with nasopharyngeal carcinoma
por: Yan, Fengqin, et al.
Publicado: (2016)

Functional Connectivity Density for Radiation Encephalopathy Prediction in Nasopharyngeal Carcinoma
por: Zhao, Lin-Mei, et al.
Publicado: (2021)

Changes of plasma cytokines and chemokines expression level in nasopharyngeal carcinoma patients after treatment with definitive intensity-modulated radiotherapy (IMRT)
por: Jin, Ya-bin, et al.
Publicado: (2017)

Clinical value of docetaxel plus cisplatin (TP) induction chemotherapy followed by TP concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma
por: Tao, Hao-Yun, et al.
Publicado: (2021)

Erlotinib-based doublet targeted therapy versus erlotinib alone in previously treated advanced non-small-cell lung cancer: a meta-analysis from 24 randomized controlled trials
por: Gao, Jian-Wei, et al.
Publicado: (2017)

Successful Treatment of Erlotinib on Metastatic Adenoid Cystic Carcinoma of the Lacrimal Gland
por: Nie, Ke-Ke, et al.
Publicado: (2018)

Fractionated stereotactic radiotherapy for 136 patients with locally residual nasopharyngeal carcinoma
por: Liu, Feng, et al.
Publicado: (2013)

Continuous inhibition of epidermal growth factor receptor phosphorylation by erlotinib enhances antitumor activity of chemotherapy in erlotinib-resistant tumor xenografts
por: IWAI, TOSHIKI, et al.
Publicado: (2011)

Radiation-Guided Peptide Delivery in a Mouse Model of Nasopharyngeal Carcinoma
por: Lin, Pei-cheng, et al.
Publicado: (2016)

Dosimetric parameters predict radiation-induced choanal stenosis in patients with nasopharyngeal carcinoma
por: Chang, Hui, et al.
Publicado: (2020)

CT-based dosiomics and radiomics model predicts radiation-induced lymphopenia in nasopharyngeal carcinoma patients
por: Huang, Qingfang, et al.
Publicado: (2023)

Retrospective Analysis of a Modified Irrigation Method for Nasopharyngeal Carcinoma Patients With Post-Radiation Nasopharyngeal Necrosis
por: Xiao, Yun, et al.
Publicado: (2021)

Dosimetric Comparisons of Volumetric Modulated Arc Therapy and Tomotherapy for Early T-Stage Nasopharyngeal Carcinoma
por: Li, Shan, et al.
Publicado: (2018)

Clinical value of nedaplatin-based chemotherapy combined with radiotherapy for locoregional advanced nasopharyngeal carcinoma: a retrospective, propensity score-matched analysis
por: Zhan, Ze-Jiang, et al.
Publicado: (2020)

Dosimetric benefit to organs at risk following margin reductions in nasopharyngeal carcinoma treated with intensity-modulated radiation therapy
por: Mao, Yan-Ping, et al.
Publicado: (2015)

Neutrophil to lymphocyte ratio as a predictor for treatment of radiation‐induced brain necrosis with bevacizumab in nasopharyngeal carcinoma patients
por: Cai, Jinhua, et al.
Publicado: (2022)

Treatment outcomes for different subgroups of nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy
por: Su, Sheng-Fa, et al.
Publicado: (2011)

Peripheral dose from megavoltage cone‐beam CT imaging for nasopharyngeal carcinoma image‐guided radiation therapy
por: Jia, Ming X., et al.
Publicado: (2012)

Prognostic significance of the long noncoding RNAs in nasopharyngeal carcinoma: a systematic review and meta-analysis
por: Guo, HuanHuan, et al.
Publicado: (2018)

Combining antiangiogenic therapy and radiation in nasopharyngeal carcinoma
por: Chen, Zhuo, et al.
Publicado: (2015)

A prospective study on radiation doses to organs at risk (OARs) during intensity-modulated radiotherapy for nasopharyngeal carcinoma patients
por: Yao, Ji-Jin, et al.
Publicado: (2016)

Nasopharyngeal brushing: a convenient and feasible sampling method for nucleic acid-based nasopharyngeal carcinoma research
por: Zhang, Pei-Fen, et al.
Publicado: (2018)

Efficacy and safety of bevacizumab plus erlotinib versus bevacizumab or erlotinib alone in the treatment of non-small-cell lung cancer: a systematic review and meta-analysis
por: Zhang, Shu, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_pnuco25oo2dn11e09rirtucvp4